Inflammation

Items 731-740 of 1004

per page
Set Descending Direction
  1. N1-Guanyl-1,7-diaminoheptane [GC7]
    CAS  150417-90-6 (parent 150333-69-0)
    AG-CR1-3702
    AG-CR1-3702-M01010 mg
    CHF 140.00
    AG-CR1-3702-M05050 mg
    CHF 420.00
    N1-Guanyl-1,7-diaminoheptane [GC7]
  2. Nafamostat . mesylate
    CAS  82956-11-4
    AG-CR1-3731
    AG-CR1-3731-M01010 mg
    CHF 60.00
    AG-CR1-3731-M05050 mg
    CHF 180.00
    Nafamostat . mesylate
  3. Narciclasine
    CAS  29477-83-6
    AG-CN2-0524
    AG-CN2-0524-C500500 µg
    CHF 90.00
    AG-CN2-0524-M0011 mg
    CHF 160.00
    Narciclasine
  4. Necrostatin-1
    CAS  4311-88-0
    AG-CR1-2900
    AG-CR1-2900-M0055 mg
    CHF 60.00
    AG-CR1-2900-M02525 mg
    CHF 180.00
    Necrostatin-1
  5. Necrosulfonamide
    CAS  1360614-48-7
    AG-CR1-3705
    AG-CR1-3705-M0055 mg
    CHF 60.00
    AG-CR1-3705-M02525 mg
    CHF 240.00
    Necrosulfonamide
  6. Nelfinavir . mesylate
    CAS  159989-65-8
    AG-CR1-3726
    AG-CR1-3726-M01010 mg
    CHF 60.00
    AG-CR1-3726-M05050 mg
    CHF 240.00
    Nelfinavir . mesylate
  7. Neobavaisoflavone
    CAS  41060-15-5
    AG-CN2-0498
    AG-CN2-0498-M0011 mg
    CHF 220.00
    Neobavaisoflavone
  8. Netrin-1 (human) (rec.)
    AG-40B-0040
    AG-40B-0040-C01010 µg
    CHF 300.00
    AG-40B-0040-30103 x 10 µg
    CHF 600.00
    AG-40B-0040-C100100 µg
    CHF 1'320.00
  9. Netrin-1 (human):Fc (human) (rec.)
    AG-40B-0075
    AG-40B-0075-C01010 µg
    CHF 350.00
    AG-40B-0075-30103 x 10 µg
    CHF 695.00
    AG-40B-0075-C100100 µg
    CHF 1'560.00
    Netrin-1 (human):Fc (human) (rec.) (Prod. No. AG-40B-0075) triggers a DCC-dependent phosphorylation of ERK1/2. Method: HEK 293 cells (Control) or HEK 293 expressing the netrin-1 receptor DCC were incubated with netrin-1 (human):Fc (
  10. Neuregulin-4 (human) (rec.)
    AG-40B-0155
    AG-40B-0155-C01010 µg
    CHF 275.00
    AG-40B-0155-30103 x 10 µg
    CHF 550.00

Items 731-740 of 1004

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.